Published by Oliver Haill on 8th June 2018
(Sharecast News) - Autolus Therapeutics has confirmed the pricing for its initial public offer on the Nasdaq index of the New York Stock Exchange, providing a monetary boost for shareholders including Syncona, the Woodford Patient Capital fund and Arix Bioscience.
URL: http://www.digitallook.com/dl/news/story/27579487/...